[Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Li Yin(Zhongda Hospital Southeast University), Xuemei Wang(Zhengzhou University), Guohua Xia(Jiangsu University), Baoan Chen(Zhongda Hospital Southeast University), Chong Gao(Nanjing Forestry University), Weiwei Wu(Shandong University of Technology), Feng Gao(East China University of Science and Technology), Jun Wang(Central South University), Gang Zhao, Wen Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Huihui Song, Yun-Yu Sun, Jia-Hua Ding, Yiqiong Liang, Fei Wang(Zhejiang Chinese Medical University), Jian Cheng(Sichuan University)
PubMed
February 1, 2010
Cited by 1
Related Papers
Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior
|Cell|2019|323
Leptin is an effective treatment for hypothalamic amenorrhea
|Proceedings of the National Academy of Sciences|2011|290
Proliferation and invasion: Plasticity in tumor cells
|Proceedings of the National Academy of Sciences|2005|176
Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women
|Metabolism|2011|168
Poly(lactic acid) (PLA) based nanocomposites—a novel way of drug-releasing
|Biomedical Materials|2007|131